A research programme by the Access to Medicine Foundation
The foundation

Access to Medicine Foundation

The Foundation stimulates and guides pharmaceutical companies to do more to improve access to medicine. It is an independent non-profit organisation.
Our programmes

Access to Medicine Index

Ranks 20 of the world’s largest pharmaceutical companies based on their efforts to address access to medicine, including in strategy, governance, R&D and pricing. By publicly recognising the best performers, the Index spurs companies to compete to be the best.

Antimicrobial Resistance Benchmark

Tracks what the 17 most active companies in antimicrobial R&D and manufacturing are doing to bring antimicrobial resistance under control. By assessing the level of action, it provides a reality check on progress against AMR.

Access to Vaccines Index

Reports what vaccine companies are doing to ensure all children can be immunised wherever they live. By uncovering what is working and where, this Index helps ensure vaccine markets also reach the poorest and most remote communities.
Type search term(s) and press enter
Often searched for
Index Ranking Vacancies 10-year analysis R&D pipelines AMR antibiotics Investors
  • Publications
  • Which information matters most? Transparency...
Published on 02 Oct 2020
Share
Publication

Which information matters most? Transparency by pharmaceutical companies that builds access to medicine plus trust and engagement

The world depends on the pharmaceutical industry for life-saving medicines and vaccines yet trust in the industry is low. Pharmaceutical companies have many opportunities to improve access to medicine – including by sharing specific information with research organisations, NGOs, governments, or the public. 

In this Viewpoint, Marijn Verhoef discusses why and when transparency by the pharma industry matters for access to medicine, and how the Access to Medicine Foundation enables transparency to improve. 

Explore further

Publication

Which information matters most? Transparency by pharmaceutical companies that builds access to medicine plus trust and engagement

The world depends on the pharmaceutical industry for life-saving medicines and vaccines yet trust in the industry is low. Pharmaceutical companies have many opportunities to improve access to medicine – including by sharing specific information with research organisations, NGOs, governments, or the public. 

In this Viewpoint, Marijn Verhoef discusses why and when transparency by the pharma industry matters for access to medicine, and how the Access to Medicine Foundation enables transparency to improve. 
Media

More engagement on neglected tropical diseases needed from drugmakers

For the special report on NTDs by Gonzalo Viña for the Financial Times, Jayasree K. Iyer talks about examples of positive engagement by pharmaceutical companies in recent years.

Publication

Medicines Patent Pool: Transparency is essential to access to medicines

In this viewpoint for Medicines Patent Pool's "10 Years of MPP" campaign, Executive Director Jayasree K. Iyer discusses the need for transparency from pharmaceutical companies in order to improve access to medicine.

Get in touch

Back to top |